Preclinical therapeutic potential of a nitrosylating agent in the treatment of ovarian cancer.
about
S-Nitrosoglutathione-mediated STAT3 regulation in efficacy of radiotherapy and cisplatin therapy in head and neck squamous cell carcinoma.Regulation of STAT3 and NF-κB activations by S-nitrosylation in multiple myeloma.Enhanced Aerobic Glycolysis by S-Nitrosoglutathione via HIF-1α Associated GLUT1/Aldolase A Axis in Human Endothelial Cells.CAISMOV24, a new human low-grade serous ovarian carcinoma cell line.
P2860
Preclinical therapeutic potential of a nitrosylating agent in the treatment of ovarian cancer.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Preclinical therapeutic potent ...... e treatment of ovarian cancer.
@ast
Preclinical therapeutic potent ...... e treatment of ovarian cancer.
@en
type
label
Preclinical therapeutic potent ...... e treatment of ovarian cancer.
@ast
Preclinical therapeutic potent ...... e treatment of ovarian cancer.
@en
prefLabel
Preclinical therapeutic potent ...... e treatment of ovarian cancer.
@ast
Preclinical therapeutic potent ...... e treatment of ovarian cancer.
@en
P2093
P2860
P1433
P1476
Preclinical therapeutic potent ...... e treatment of ovarian cancer.
@en
P2093
Jacie L Maguire
Mandar Deshpande
Ramandeep Rattan
Shailendra Giri
Viji Shridhar
Zachary Johnson
P2860
P304
P356
10.1371/JOURNAL.PONE.0097897
P407
P577
2014-06-02T00:00:00Z